Baillie Gifford & CO Beam Therapeutics Inc. Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

A detailed history of Baillie Gifford & CO transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 357,698 shares of BEAM stock, worth $9.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

357,698

Previous 623,640 42.64%

Holding current value

$9.05 Million

Previous $14.6 Million 40.02%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$22.57 - $33.14 $6 Million - $8.81 Million	-265,942 Reduced 42.64%	357,698 $8.76 Million
Q2 2024 Jul 25, 2024	SELL	$21.22 - $32.66 $2.73 Million - $4.21 Million	-128,754 Reduced 17.11%	623,640 $14.6 Million
Q1 2024 May 01, 2024	SELL	$23.46 - $45.07 $275,162 - $528,626	-11,729 Reduced 1.53%	752,394 $24.9 Million
Q4 2023 Jan 26, 2024	SELL	$17.69 - $30.76 $1.97 Million - $3.43 Million	-111,624 Reduced 12.75%	764,123 $20.8 Million
Q3 2023 Nov 13, 2023	BUY	$23.01 - $32.46 $8.1 Million - $11.4 Million	352,014 Added 67.21%	875,747 $21.1 Million
Q2 2023 Jul 28, 2023	BUY	$29.32 - $35.99 $2.08 Million - $2.55 Million	70,972 Added 15.68%	523,733 $16.7 Million
Q1 2023 May 03, 2023	SELL	$30.15 - $48.79 $62,320 - $100,848	-2,067 Reduced 0.45%	452,761 $13.9 Million
Q4 2022 Jan 24, 2023	BUY	$36.73 - $51.6 $2.56 Million - $3.59 Million	69,610 Added 18.07%	454,828 $17.8 Million
Q3 2022 Oct 27, 2022	BUY	$39.79 - $70.31 $14.9 Million - $26.3 Million	374,545 Added 3509.28%	385,218 $18.4 Million
Q4 2021 Jan 20, 2022	SELL	$68.02 - $99.06 $1,836 - $2,674	-27 Reduced 0.25%	10,673 $851,000
Q3 2021 Oct 19, 2021	BUY	$84.37 - $133.6 $861,670 - $1.36 Million	10,213 Added 2097.13%	10,700 $931,000
Q2 2021 Aug 02, 2021	SELL	$64.12 - $128.71 $2,051 - $4,118	-32 Reduced 6.17%	487 $63,000
Q1 2021 May 06, 2021	BUY	$71.28 - $120.75 $1,710 - $2,898	24 Added 4.85%	519 $42,000
Q4 2020 Feb 10, 2021	BUY	$22.24 - $95.63 $11,008 - $47,336	495 New	495 $40,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Beam Therapeutics Inc. Transaction History